• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. CAR-NK-Zellen: die nächste Innovation der Krebsimmuntherapie?
 
  • Details
  • Full
Options
May 2025
Journal Article
Title

CAR-NK-Zellen: die nächste Innovation der Krebsimmuntherapie?

Abstract
CAR-NK cells offer a promising immunotherapy approach, addressing key CAR-T cell limitations like reduced toxicity risks while retaining targeted efficacy. They combine the innate cytotoxicity of natural killer (NK) cells with the targeted action of chimeric antigen receptors (CAR). Their potential lies in efficacy, tolerability and the possibility of off-the-shelf production, enabling rapid treatment access. However, CAR-NK cells are still in early development with ongoing clinical trials. The next years will determine their potential for clinical application.
Author(s)
Schindler, Katharina
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Schmiedel, Dominik  
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
Journal
Biospektrum  
Open Access
DOI
10.1007/s12268-025-2470-4
Language
German
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024